Rx Rebates To Foreign Governments Could Blunt Reimportation
Executive Summary
Drug manufacturers' recent pricing actions overseas may signal a new strategy to counter proposals for reimporting drugs into the U.S., American Enterprise Institute fellow Scott Gottlieb, MD, suggested Nov. 9